Abstract
Background Regulation of medical devices has seriously lagged, especially in Resource-Limited Settings (RLS). There are disparities in regulating medical devices; in the African region, it is below the global average. This may translate into poor access to quality-assured medical devices and result in undesirable health outcomes. Operational readiness to regulate medical devices in Zimbabwe at the Medicines Control Authority of Zimbabwe (MCAZ), the designated National Regulatory Authority (NRA), is vital for planning and implementation. The study aimed to assess the readiness of the MCAZ to regulate medical devices by identifying the strengths and gaps and proposing an institutional development plan that can be monitored and evaluated to assess progress over time.
Methods Quantitative study was conducted using the World Health Organization (WHO) Global Benchmarking Tool+ medical devices (GBT+ medical devices) methodology to evaluate the medical devices regulatory oversight at the MCAZ. Data were collected between June and August 2022 using standard checklists to assess the quality of implementation of medical devices’ regulatory functions; National Regulatory System (RS), Registration and Market Authorisation (MA), Vigilance (VL), Market Surveillance and Control (MC), Licensing Establishment (LI), Regulatory Inspection (RI), Laboratory Testing(LT), and Clinical Trials (CTs) Oversight.
Results The MCAZ attained maturity level 1, with an RS score of 79%, MA-44%, VL-27%, MC-40%, LI-62%, RI-68%, LT-88%, and CT-18%. Condoms and gloves were the only regulated medical devices. Indicators on legal provisions, regulations, and guidelines across the regulatory functions were below the optimum requirement.
Conclusion The legal provisions, regulations, and guidelines are inadequate for effectively regulating medical devices. The medical devices regulation requires review for it to be robust and fit-for-purpose, responsive, oriented to the outcome, predictable based on a standard and transparent approach, and the level of scrutiny proportionate to the risk classification of the medical device.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The author(s) received no specific funding for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Medical Research Council of Zimbabwe, (Approval reference number MRCZ/A/2900). 20 Cambridge Rd, Harare, Zimbabwe Phone: +263 24 2791792 Email: mrcz{at}mrcz.org.zw
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All relevant data are within the manuscript and its Supporting Information files.
